HeartBeam Announces First Commercial Customer as ClearCardio Brings Groundbreaking 12-Lead ECG Technology to High-Growth Preventive Cardiology Market

Stock Information for Heartbeam Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Heartbeam Inc.

HeartBeam Reports Fourth Quarter and Full Year 2025 Results
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
HeartBeam to Attend Investor and Industry Conferences in March, Focused on Providing Updates on Commercial Launch and Unveiling 12-Lead ECG Extended Wear Patch
HeartBeam Announces First Patient Enrollments in Heart Attack Detection Pilot Study
HeartBeam to Host Fourth Quarter Full Year 2025 Results Conference Call on Thursday, March 12, 2026 at 4:30 p.m. Eastern Time
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.